A male mouse model for metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma
The third target, glucagon receptors, is what makes Retatrutide stand apart from most other weight loss peptides
Their pharmacological targets, clinical indications, and regulatory statuses are markedly different, and they should not be considered interchangeable or directly comparable therapeutic alternatives
Still, the energy and muscle-preservation benefits hold up
The authors noted that delayed gastric emptying and reduced thirst may require more active treatment with bulk-forming laxatives like psyllium, stool softeners such as docusate sodium, or osmotic or stimulant laxatives like polyethylene glycol
That said, some patients do experience mild stimulant-like effects from the bupropion component, including increased energy, reduced appetite, and occasionally insomnia